Burns Archives - PharmaLive

MediWound shares tumble as FDA declines to approve treatment for burns

Biomedical Advanced Research and Development Authority (BARDA), Burns, Business, FDA, Shares, Tissue

The U.S. drug regulator on June 29 declined to approve MediWound Ltd.’s topical burn treatment NexoBrid, sending the company’s shares tumbling in trading.

Mallinckrodt Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft Regenerative Tissue

Autograft, Biopharmaceutical, Clinical Trials, Deep Partial-Thickness Thermal Burns, R&D, Regenerative Tissue

Mallinckrodt plc announced positive top-line results from the global biopharmaceutical company’s pivotal Phase 3 clinical trial of the investigational StrataGraft regenerative tissue.

Argentum Medical Awarded $8.4M BARDA Contract for Silverlon Wound Technology to Prepare U.S. for Nuclear and Radiation Emergencies

Biomedical Advanced Research and Development Authority (BARDA), Burns, Business, Department of Health and Human Services (HHS), Military, Nuclear emergencies, Radiation, Skin Health, Studies, Wound Technology

To prepare for radiological and nuclear emergencies, the U.S. Department of Health and Human Services (HSS) announced it will work with Argentum Medical LLC to repurpose the company’s commercial Silverlon technology for radiation injuries of the skin.